Health · 1 sources covering this

STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs

Turkish regulators are investigating Teva Pharmaceutical for allegedly manipulating the patent system and disparaging rival drugs.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs
Turkish regulators are investigating Teva Pharmaceutical for allegedly manipulating the patent system and disparaging rival drugs.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/2c61d1f6a0942720c3c2cf3f9c2343a4449b2b13"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs"></iframe>

STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs

How 1 sources are covering this

STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs

More from Health

STAT+: How Trump’s funding cuts are reshaping the health system

STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026

STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM

STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs

More from Health

STAT+: How Trump&#8217;s funding cuts are reshaping the health system

STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026

STAT+: FDA promises new AI guidance, and what happened at Epic&#8217;s UGM

STAT+: Pharmalittle: We&#8217;re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more

Reader

Trust & legal

Across the network

STAT+: How Trump’s funding cuts are reshaping the health system

STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM

STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more